Related Experiment Video
Updated: Jul 27, 2025
In Vivo Fiber-Coupled Pre-Clinical Confocal Laser-scanning Endomicroscopy pCLE of Hippocampal Capillaries in Awake Mice
Published on: April 21, 2023
Astrocytic CD44 Deficiency Reduces the Severity of Kainate-Induced Epilepsy
Patrycja K Kruk1, Karolina Nader2, Anna Skupien-Jaroszek1
1Laboratory of Cell Biophysics, Nencki Institute of Experimental Biology, Polish Academy of Sciences, 3 Pasteura St, 02-093 Warsaw, Poland.
Targeting CD44 in astrocytes offers a new epilepsy treatment strategy. Removing CD44 in brain cells reduced seizure progression and altered synapse structure, suggesting CD44 is key in epilepsy development.
Area of Science:
- Neuroscience
- Cell Biology
- Epilepsy Research
Background:
- Epilepsy impacts millions globally, lacking universal treatments.
- Astrocytes, abundant brain cells, present novel therapeutic targets.
- CD44, an astrocyte protein, is upregulated post-seizure and linked to epilepsy.
Purpose of the Study:
- To investigate the role of CD44 in astrocytes in epilepsy.
- To assess the impact of CD44 absence on epileptogenesis and synaptic structure.
Main Methods:
- Utilized transgenic mice with astrocyte-specific CD44 knockout.
- Induced epilepsy using kainic acid.
- Examined ultrastructural changes at the tripartite synapse.
Main Results:
- CD44 deficiency in hippocampal astrocytes reduced reactive astrogliosis.
- Decreased progression of kainic acid-induced epileptogenesis.
- Observed increased dendritic spine number and altered astrocyte-synapse contacts.
Conclusions:
- CD44 signaling is crucial for astrocytic synapse coverage in the hippocampus.
- Astrocytic alterations mediated by CD44 impact epilepsy pathology.
Related Concept Videos
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
01:17Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
01:14Antiepileptic Drugs: Glutamate Antagonists
01:24Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...